We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$209M
AUM Growth
-$111K
Cap. Flow
-$4.23M
Cap. Flow %
-2.03%
Top 10 Hldgs %
77.78%
Holding
58
New
2
Increased
2
Reduced
27
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$593K
2
ILMN icon
Illumina
ILMN
+$273K
3
WU icon
Western Union
WU
+$216K
4
INTU icon
Intuit
INTU
+$550

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.94M
2
CELG
Celgene Corp
CELG
+$670K
3
ADBE icon
Adobe
ADBE
+$505K
4
AAPL icon
Apple
AAPL
+$450K
5
CSCO icon
Cisco
CSCO
+$254K

Sector Composition

Rank Sector Weight
1 Healthcare 40.73%
2 Technology 36.19%
3 Communication Services 9.27%
4 Consumer Discretionary 4%
5 Industrials 3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ED icon
51
Consolidated Edison
ED
$40.2B
$250K 0.12%
2,650
SO icon
52
Southern Company
SO
$107B
$243K 0.12%
3,931
WU icon
53
Western Union
WU
$2.23B
$231K 0.11%
+9,988
New +$216K
GE icon
54
GE Aerospace
GE
$389B
$227K 0.11%
5,084
-401
-7% -$18.8K
ABT icon
55
Abbott
ABT
$187B
$215K 0.1%
2,568
INTU icon
56
Intuit
INTU
$88.1B
$210K 0.1%
792
+2
+0.3% +$550
VTAK icon
57
Catheter Precision
VTAK
$977K
0
RIO icon
58
Rio Tinto
RIO
$162B
-3,400
Closed -$212K

Similar funds

Bourne Lent Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Bourne Lent Asset Management held 58 positions worth $209M, down 0.05% from $209M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bourne Lent Asset Management's Q3 2019 filing shows 2 new, 2 increased, 27 reduced and 1 closed positions. Its largest new stake was Illumina: 925 shares worth $274K. The largest sale was Idexx Laboratories, an estimated $1.94M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 41% a quarter earlier, followed by Technology and Communication Services.

  • Bourne Lent Asset Management's largest Q3 2019 buy was Illumina: 925 shares worth $274K.
  • Bourne Lent Asset Management added most to Pacific Biosciences in Q3 2019, an estimated $593K increase.
  • Bourne Lent Asset Management's biggest Q3 2019 reduction was Idexx Laboratories, cutting an estimated $1.94M.
  • Bourne Lent Asset Management fully exited Rio Tinto in Q3 2019, selling an estimated $212K.
  • Bourne Lent Asset Management's ten largest holdings make up 78% of its $209M portfolio in Q3 2019.
  • Bourne Lent Asset Management opened 2 new positions and closed 1 in Q3 2019.
  • Bourne Lent Asset Management's portfolio value fell 0.05% quarter-over-quarter to $209M.

Based on Bourne Lent Asset Management's 13F filing for Q3 2019, filed 24 Oct 2019.